Evaluating effectiveness of maternal RSV vaccination and nirsevimab for severe RSV-related illness in infants

A new study found that infants receiving maternal Respiratory Syncytial Virus (RSV) vaccination or Nirsevimab after birth had ...

MSD secures EC approval for Enflonsia to prevent infant RSV infection

Merck & Co (MSD) has received the European Commission (EC) approval for Enflonsia (clesrovimab), indicated to prevent ...
The New England Journal of Medicine

Clesrovimab for Prevention of RSV Disease in Healthy Infants

Clesrovimab is a long-acting investigational monoclonal antibody against site IV of the respiratory syncytial virus (RSV) fusion protein. Data regarding the safety and efficacy of clesrovimab in ...

Ambient air pollution is associated with respiratory infection burden in the first year of life

Ambient air pollution is associated with respiratory infection burden in the first year of life, according to preliminary ...
MobiHealthNews

Masimo's respiration sensor receives FDA nod for neonatal, infant use

Furthering its move into the neonatal space, this morning non-invasive patient monitoring device and sensor maker Masimo announced that it landed FDA clearance for its acoustic respiration sensor, the ...